Literature DB >> 15762813

Attitudes toward benzodiazepines over the years.

Jerrold F Rosenbaum1.   

Abstract

Benzodiazepines have been used extensively for the treatment of anxiety and related disorders since the 1960s. Although they have been proven to be effective as first-line treatment for anxiety disorders, during the 1980s public perception and concern for abuse liability and physical dependence with long-term use gave rise to a great deal of controversy. Negative perceptions toward the use of benzodiazepines for treating anxiety not only caused severely ill patients to go untreated or under-treated but also called into question whether the illness itself was worthy of treatment. Although new pharmacologic and psychological treatments for anxiety are available, psychopharmacologists continue to endorse benzodiazepines as primary or adjunct treatment for anxiety disorders. The intent of this article is to provide a historic overview of these issues and to offer some general clinical principles to help minimize the risk of abuse and dependence with benzodiazepine use.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762813

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  11 in total

Review 1.  Prescription privileges for psychologists: a comprehensive review and critical analysis of current issues and controversies.

Authors:  Kim L Lavoie; Silvana Barone
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Psychiatrist decision-making towards prescribing benzodiazepines: the dilemma with substance abusers.

Authors:  Carla Beth Marienfeld; Ece Tek; Esperanza Diaz; Richard Schottenfeld; Marek Chawarski
Journal:  Psychiatr Q       Date:  2012-12

Review 3.  Glutamate and anxiety disorders.

Authors:  Jonathan M Amiel; Sanjay J Mathew
Journal:  Curr Psychiatry Rep       Date:  2007-08       Impact factor: 5.285

4.  Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review.

Authors:  Boadie W Dunlop; Paula G Davis
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

5.  Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation.

Authors:  Antonio Veronese; Massimo Garatti; Andrea Cipriani; Corrado Barbui
Journal:  Eur J Clin Pharmacol       Date:  2007-07-10       Impact factor: 2.953

6.  Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions.

Authors:  Hui-wen Keri Yang; Linda Simoni-Wastila; Ilene H Zuckerman; Bruce Stuart
Journal:  Psychiatr Serv       Date:  2008-04       Impact factor: 3.084

7.  Perceptions of benzodiazepine dependence among women age 65 and older.

Authors:  Sarah L Canham; Joseph Gallo; Linda Simoni-Wastila
Journal:  J Gerontol Soc Work       Date:  2014-09-24

Review 8.  Polydrug abuse: a review of opioid and benzodiazepine combination use.

Authors:  Jermaine D Jones; Shanthi Mogali; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-08-02       Impact factor: 4.492

9.  Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain.

Authors:  Cristina Lopez-Peig; Xavier Mundet; Bartomeu Casabella; Jose Luis del Val; David Lacasta; Eduard Diogene
Journal:  BMC Res Notes       Date:  2012-12-13

10.  High-Dose Benzodiazepine Dependence: A Qualitative Study of Patients' Perceptions on Initiation, Reasons for Use, and Obtainment.

Authors:  Michael Liebrenz; Marcel Schneider; Anna Buadze; Marie-Therese Gehring; Anish Dube; Carlo Caflisch
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.